Skip to content
healthcare.dev

Rasuvo

NDC 59137-525, methotrexate, injection, solution, from Medexus Pharma Inc..

Product NDC
59137-525
Status
Listed
Labeler
Medexus Pharma Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA205776
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59137-525 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHOTREXATE SODIUM17.5 mg/.35mL

Pharmacologic classes

Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]

Package NDCNDC-11Package
59137-525-01591370525011 PACKAGE in 1 CARTON (59137-525-01) / .35 mL in 1 PACKAGE (59137-525-00)
59137-525-04591370525044 PACKAGE in 1 CARTON (59137-525-04) / .35 mL in 1 PACKAGE (59137-525-00)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d0075461-0e7e-4967-9c9b-d6440e912c0e
  • NADAC price for package 59137052504

    GET /v1/drugs/nadac/59137052504

Use it

Look up 59137-525 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59137-525 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59137-525. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.